Replimune Group, Inc. (REPL)
12.92
-0.32
(-2.42%)
USD |
NASDAQ |
Sep 11, 16:00
12.94
+0.02
(+0.12%)
After-Hours: 20:00
Replimune Group Market Cap : 1.085B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.085B |
| September 10, 2026 | 1.112B |
| September 09, 2026 | 1.214B |
| September 08, 2026 | 1.240B |
| September 04, 2026 | 1.263B |
| September 03, 2026 | 1.284B |
| September 02, 2026 | 1.342B |
| September 01, 2026 | 1.316B |
| August 31, 2026 | 1.285B |
| August 28, 2026 | 1.302B |
| August 27, 2026 | 1.310B |
| August 26, 2026 | 1.334B |
| August 25, 2026 | 1.327B |
| August 24, 2026 | 1.235B |
| August 21, 2026 | 1.240B |
| August 20, 2026 | 1.180B |
| August 19, 2026 | 1.244B |
| August 18, 2026 | 1.308B |
| August 17, 2026 | 1.229B |
| August 14, 2026 | 1.257B |
| August 13, 2026 | 1.276B |
| August 12, 2026 | 1.280B |
| August 11, 2026 | 1.129B |
| August 10, 2026 | 1.131B |
| August 07, 2026 | 997.57M |
| Date | Value |
|---|---|
| August 06, 2026 | 1.064B |
| August 05, 2026 | 978.54M |
| August 04, 2026 | 985.99M |
| August 03, 2026 | 985.16M |
| July 31, 2026 | 926.43M |
| July 30, 2026 | 447.50M |
| July 29, 2026 | 447.50M |
| July 28, 2026 | 442.54M |
| July 27, 2026 | 713.85M |
| July 24, 2026 | 802.35M |
| July 23, 2026 | 865.22M |
| July 22, 2026 | 889.21M |
| July 21, 2026 | 909.89M |
| July 20, 2026 | 869.35M |
| July 17, 2026 | 846.19M |
| July 16, 2026 | 787.46M |
| July 15, 2026 | 800.70M |
| July 14, 2026 | 816.42M |
| July 13, 2026 | 821.79M |
| July 10, 2026 | 909.06M |
| July 09, 2026 | 918.98M |
| July 08, 2026 | 919.81M |
| July 07, 2026 | 952.07M |
| July 06, 2026 | 948.76M |
| July 02, 2026 | 957.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 57.44B |
| Kalaris Therapeutics, Inc. | 80.46M |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Oncolytics Biotech, Inc. | 92.92M |
| Sangamo Therapeutics, Inc. | 61.52M |
Market Cap Related Metrics
| Price to Book Value | 10.27 |
| Price | 12.92 |
| Earnings Yield | -25.38% |